Onychomycosis in older patients

Aging Health

Volumn 2, Issue 5, 2006, Pages 865-870

  Piérard, Gérald E ^a   Arrese, Jorge E ^a   Piérard Franchimont, Claudine ^a   Quatresooz, Pascale ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Dermatophyte; Histomycology; Nondermatophytic mold; Onychomycosis; Yeast

Indexed keywords

ANTIFUNGAL AGENT; POTASSIUM HYDROXIDE;

ACREMONIUM; AGE; ASPERGILLUS; COMORBIDITY; COMPUTER ANALYSIS; DERMATOPHYTE; DIAGNOSTIC ACCURACY; EPIDEMIOLOGICAL DATA; FLOW CYTOMETRY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GEOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MEDICAL DECISION MAKING; MICROSCOPY; NAIL DISEASE; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; REVIEW; SCOPULARIOPSIS BREVICAULIS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TRICHOPHYTON; YEAST;

EID: 33750981259     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.2.5.865     Document Type: Review

References (45)

1. Piérard GE: Skin ageing, a fresh look at an old story. J. Cosmet. Dermatol. 3, 1 (2004).
2. Piérard GE: Ageing across the life span: time to think again. J. Cosmet. Dermatol. 3, 50-53 (2004).
3. Cohen PR, Scher RK: Geriatric nail disorder: diagnosis and treatment. J. Am. Acad. Dermatol. 26, 521-534 (1992).
4. Tosti A, Piraccini BM, Mariani R et al.: Are local and systemic conditions important for the development of onychomycoses. Eur. J. Dermatol. 1, 41-44 (1998).
5. Sigurgeirsson B, Steingrimsson O: Risk factors associated with onychomycosis. J. Eur. Acad. Dermatol. Venereol. 18, 48-51 (2004).
6. Gupta AK, Humke S: The prevalence and management of onychomycosis in diabetic patients. Eur. J. Dermatol. 10, 379-384 (2000).
7. Piérard GE, Piérard-Franchimont C: The nail under fungal siege in patients with Type II diabetes mellitus. Mycoses 48, 339-342 (2005).
8. Gupta AK, Lynde CW, Jain HC et al.: A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br. J. Dermatol. 136, 786-789 (1997).
9. Kielberg-Larsen G, Haedersdal M, Svejgaard EL: The prevalence of onychomycosis in patients with psoriasis and other skin diseases. Acta Derm. Venereol. 83, 206-209 (2003).
10. Piérard-Franchimont C, Arrese JE, Hermanns-Lê T, Piérard GE: Epidemiology of onychomycosis assessed by histomycology in psoriatic patients. J. Mycol. Med. (2006) (In press).
11. Gupta AK, Gupta MA, Summerbell RC et al.: The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J. Eur. Acad. Dermatol. Venereol. 14, 466-469 (2000).
12. Saez de Ocariz M, Arenas R, Ranero-Juarez GA: Frequency of toenail onychomycosis in patients with cutaneous manifestations of chronic venous insufficiency. Int. J. Dermatol. 40, 18-25 (2001).
13. Elewski GE, Charif M: Prevalence of onychomycosis in patients attending a dermatology clinic in Northeastern Ohio for other conditions. Arch. Dermatol. 133, 1172-1173 (1997).
14. Levy LA: Epidemiology of onychomycosis in special risk populations. J. Am. Pod. Med. Ass. 87, 546-550 (1997).
15. Schein JR, Gause D, Strier DM: Onychomycosis: baseline results of an observational study. J. Am. Podiatr. Med. Assoc. 87, 512-519 (1997).
16. Gill D, Marks R: A review of the epidemiology of tinea unguium in the community. Aust. J. Dermatol. 40, 6-13 (1999).
17. Haneke E, Roseeuw D: The scope of onychomycosis: epidemiology and clinical features. Int. J. Dermatol. 38, S7-S12 (1999).
18. Ghannoum MA, Hajjeh RA, Scher R et al.: A large-scale North American study of fungi isolated from nails: the frequency of onychoycosis, fungal distribution, and antifungal susceptibility patterns. J. Am. Acad. Dermatol. 43, 641-648 (2000).
19. Gupta AK, Jain HC, Lynde CW et al.: Prevalence and epidemiology of onychomycois in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J. Am. Acad. Dermatol. 43, 244-248 (2000).
20. Piérard GE: Onychomycosis and other superficial fungal infections on the foot in the elderly: a pan European survey. Dermatology 202, 220-224 (2001).
21. Elewski BE, Leyden J, Rinaldi MG, Atillasoy E: Office practice-based confirmation of onychomycosis: a US nationwide prospective survey. Arch. Intern. Med. 162, 2133-2138 (2002).
22. Burzykowski T, Malenberghs G, Abeck D et al.: High prevalence of foot diseases in Europe: results of the Achilles project. Mycoses 46, 496-505 (2003).
23. Faergemann J, Baran R: Epidemiology, clinical presentation and diagnosis of onychomycosis. Br. J. Dermatol. 149, 1-4 (2003).
24. Arrese JE, Valverde JC, Piérard GE: Un nuevo enfoque sobre la epidemiologia de las onicomicosis. Rev. Iberoamer. Micol. 22, 163-166 (2005).
25. Piérard GE, Arrese E, Pierre S et al.: Diagnostic microscopique des onychomycoses. Ann. Dermatol. Venereol. 121, 25-29 (1994).
26. Arrese JE, Piérard-Franchimont C, Piérard GE: Facing up to the diagnostic uncertainty and management of onychomycoses. Int. J. Dermatol. 38, S1-S6 (1999).
27. Arrese JE, Piérard-Franchimont C, Piérard GE: A plea to bridge the gap between antifungals and onychomycosis management. Am. J. Clin. Dermatol. 2, 281-284 (2001).
28. Arrese JE, Piérard GE: Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 207, 255-260 (2003).
29. Summerbell RC, Kane J, Krajden S: Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 32, 609-619 (1989).
30. Summerbell RC: Epidemiology and ecology of onychomycosis. Dermatology 194, S32-S36 (1997).
31. Haneke E, Roseeuw D: The scope of onychomycosis: epidemiology and clinical features. Int. J. Dermatol. 38, 7-12 (1999).
32. Arrese JE, Quatresooz P, Piérard-Franchimont C, Piérard GE: Histomycologie unguéale. Ann. Dermatol. Venereol. 130, 1254-1259 (2003).
33. Piérard GE, Quatresooz P, Arrese JE: Spotlight on nail histomycology. Dermatol. Clin. 24, 371-374 (2006).
34. Gianni C, Morelli V, Cerri A et al.: Usefulness of histological examination for diagnosis of onychomycosis. Dermatology 202, 283-288 (2001).
35. Scherer WP, McCreary JP, Hayes WW: The diagnosis of onychomycosis in a geriatric population. A study of 450 cases in South Florida. J. Am. Podiatr. Med. Assoc. 91, 456-464 (2001).
36. Piérard GE, Arrese JE, De Doncker P, Piérard-Franchimont C: Present and potential diagnostic techniques in onychomycosis. J. Am. Acad. Dermatol. 34, 273-277 (1996).
37. Elewski BE: Diagnostic techniques for confirming onychomycosis. J. Am. Acad. Dermatol. 35, S6-S9 (1996).
38. Baran R, Gupta AK, Piérard GE: Pharmacotherapy of onychomycosis. Exp. Opin. Pharmacother. 6, 609-624 (2005).
39. Haldane DJ, Robart E: A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infection. Diag. Microbiol. Infect. Dis. 13, SS7-SS9 (1990).
40. Piérard GE, Arrese JE, Piérard-Franchimont C, Quatresooz P: Onychomycosis under the microscope. Publ. Janssen Pharmaceutica, Beerse 1-51 (2003).
41. Suarez SM, Silvers DN, Scher RK et al.: Histologic evaluation of nail clippings for diagnosing onychomycosis. Arch. Dermatol. 127, 1517-1519 (1991).
42. Machler BC, Kirsner RS, Elgart GW: Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. Cutis 61, 217-229 (1998).
43. Weinberg, JM, Koestenblatt EK, Tutrone WD et al.: Comparison of diagnostic methods in the evaluation of onychomycosis. J. Am. Acad. Dermatol. 19, 193-197 (2003).
44. Piérard GE: Spores, sporodochia and fomites in onychomycosis. Dermatology 213, 169-172 (2006).
45. Arrese JE, Piérard-Franchimont C, Greimers R, Piérard GE: Fungi in onychomycosis: a study by immunohistochemistry and dual flow cytometry. J. Eur. Acad. Dermatol. Venereol. 4, 123-130 (1995).